Benjamin Kornitzer is Chief Med. & Quality Officer at agilon health, inc. (AGL). They have made 25 open-market trades across 1 company since 2021, most recently 2024-03-14.
CIK 0001855842
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 25 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| AGL | 62,058 | $5.3M |
Shares reported on the most recent Form 4, priced at the 2024-03-18 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AGL | SELL | 2023-03-22 | 2023-03-24 | $27.94 | $905K | -10.2% | -13.1% | -41.9% |
| AGL | SELL | 2023-03-15 | 2023-03-17 | $23.81 | $1.3M | +2.8% | +5.3% | -28.2% |
| AGL | SELL | 2023-03-07 | 2023-03-09 | $24.40 | $790K | +17.8% | +13.2% | -13.4% |
| AGL | SELL | 2023-02-14 | 2023-02-16 | $22.99 | $1.6M | -9.4% | +15.5% | -0.7% |
| AGL | SELL | 2023-02-01 | 2023-02-03 | $22.81 | $1.7M | +8.3% | +11.7% | +11.4% |
| AGL | SELL | 2023-01-19 | 2023-01-23 | $19.79 | $641K | +10.2% | +7.2% | +21.9% |
| AGL | SELL · 10b5-1 | 2023-01-05 | 2023-01-09 | $15.49 | $84K | +16.0% | +26.4% | +52.5% |
| AGL | SELL | 2022-12-15 | 2022-12-19 | $17.12 | $370K | -1.3% | +20.8% | +64.4% |
| AGL | SELL | 2022-12-05 | 2022-12-07 | $17.76 | $383K | -3.9% | -10.1% | +44.9% |
| AGL | SELL | 2022-11-16 | 2022-11-18 | $17.97 | $388K | +6.5% | -2.9% | +39.1% |
| AGL | SELL | 2022-11-01 | 2022-11-03 | $19.78 | $427K | -2.5% | -8.1% | +18.4% |
| AGL | SELL | 2022-10-14 | 2022-10-18 | $21.79 | $353K | -4.1% | -20.7% | -5.8% |
| AGL | SELL | 2022-10-03 | 2022-10-05 | $23.72 | $768K | -10.7% | -27.5% | -32.8% |
| AGL | SELL | 2022-09-26 | 2022-09-28 | $22.86 | $740K | -7.9% | -14.0% | -31.2% |
| AGL | SELL | 2022-09-08 | 2022-09-12 | $22.82 | $985K | -6.5% | -6.4% | -26.3% |
| AGL | SELL | 2022-08-23 | 2022-08-25 | $20.69 | $447K | +0.5% | +1.5% | -25.7% |
| AGL | SELL | 2022-08-04 | 2022-08-08 | $25.02 | $810K | -22.9% | -17.3% | -35.1% |
| AGL | SELL | 2022-07-15 | 2022-07-19 | $26.41 | $855K | -5.0% | -21.4% | -19.1% |
| AGL | SELL | 2022-07-01 | 2022-07-06 | $22.87 | $2.0M | +5.4% | +5.3% | -0.1% |
| AGL | SELL | 2022-06-22 | 2022-06-24 | $19.98 | $431K | +17.7% | +14.0% | +1.9% |
| AGL | SELL | 2022-06-09 | 2022-06-13 | $20.11 | $434K | +18.5% | +39.1% | +33.4% |
| AGL | SELL | 2022-05-27 | 2022-06-01 | $19.68 | $425K | +0.9% | +23.0% | +11.1% |
| AGL | SELL | 2022-05-10 | 2022-05-12 | $16.19 | $345K | +8.4% | +7.0% | +55.8% |
| AGL | SELL | 2022-04-27 | 2022-04-29 | $18.49 | $399K | -7.6% | +8.6% | +43.2% |
| AGL | SELL | 2022-04-18 | 2022-04-20 | $22.39 | $572K | -15.6% | -10.6% | +19.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.